Loading...

A clinical and pharmacokinetic study of indomethacin in standard and slow release formulations.

Fifteen patients with rheumatoid arthritis received indomethacin in three treatment schedules; indomethacin retard 75 mg twice daily; indomethacin capsules 50 mg three times daily; and indomethacin 100 mg suppository at night with 50 mg by mouth each morning. The study was a double-blind, double-dum...

Full description

Saved in:
Bibliographic Details
Main Authors: Adams, K R, Halliday, L D, Sibeon, R G, Baber, N, Littler, T, Orme, M L
Format: Artigo
Language:Inglês
Published: 1982
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC1427762/
https://ncbi.nlm.nih.gov/pubmed/7104182
Tags: Add Tag
No Tags, Be the first to tag this record!